Afqlir® (aflibercept) – Biosimilar Medicine Fact Sheet (A4)
An A4 fact sheet developed to provide clear, evidence-based information on Afqlir®, a biosimilar aflibercept listed on the Pharmaceutical Benefits Scheme (PBS). It explains what biosimilars are, how similarity is assessed, and how Afqlir® works in treating retinal conditions. Designed for healthcare professionals and patients, it supports informed decision-making by outlining safety, efficacy, and regulatory standards in an accessible format.

Leadtime:

• Production: 2-3 working days
• Delivery 3-6 working days